2 weeks Two weeks before the highly antisipated FDA approval, Liminial essentially paid Kedrion 25 Million to take this technology that cost shareholders 100's of millions and many years to develop! Why??
Kedrion could expect to recieve 30% of a voucher, say 30 Million, but paid only 5 million and walks away with an approved drug that had cost shareholders multiples. Their game of screwing shareholders is not over.